Avinash Gulanikar
Urology · Flowood, MSNPI 1013098995
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 231 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,117 and has fallen 73.6% since, to $295 in 2023.
Across 231 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dendreon Pharmaceuticals LLC$735
- Astellas Pharma US Inc$566
- Johnson & Johnson$565
- Pfizer$311
- Bayer$227
- Merck$216
- plus $1K from 31 others
What the payments were for
- Food & beverage$3,92597%
- Education$1093%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 32 | $735 |
| Astellas Pharma US Inc | 38 | $566 |
| Johnson & Johnson | 39 | $565 |
| Pfizer | 19 | $311 |
| Bayer | 14 | $227 |
| Merck | 11 | $216 |
| AbbVie(2 entities) | 13 | $185 |
| Tolmar Pharmaceuticals, Inc. | 7 | $130 |
| Boston Scientific | 5 | $126 |
| Blue Earth Diagnostics | 5 | $96 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $85 |
| Amgen | 4 | $72 |
| Urovant Sciences Inc | 4 | $63 |
| Foundation Medicine, Inc. | 3 | $61 |
| Urogen Pharma, Inc. | 3 | $47 |
| Cook Medical LLC | 3 | $46 |
| Rochester Medical Corporation | 3 | $45 |
| Alnylam Pharmaceuticals Inc. | 2 | $45 |
| Verity Pharmaceuticals Inc. | 2 | $44 |
| AstraZeneca | 3 | $43 |
| Janssen Scientific Affairs, LLC | 1 | $32 |
| Photocure Inc | 2 | $31 |
| Coloplast | 2 | $27 |
| Novartis | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 2 | $23 |
| Teleflex LLC | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Progenics Pharmaceuticals, Inc. | 1 | $21 |
| Tolmar, Inc. | 1 | $16 |
| Mission Pharmacal Company | 1 | $15 |
| Hollister Incorporated | 1 | $15 |
| Travere Therapeutics, Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Myovant Sciences Inc. | 1 | $14 |
| Myriad Genetic Laboratories, Inc. | 1 | $14 |
| Acerus Pharmaceuticals Corporation | 1 | $12 |
| Clovis Oncology, Inc. | 1 | $11 |
How this compares
$4,034 in reported general payments places this provider in the 55th percentile of 94 urology providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 14 | $10,641 |
| Tamsulosin Hcl | 57 | $689 |
| Finasteride | 28 | $325 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $566 | $10,64114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 94 urology providers in Mississippi.
Other urology in Flowood
- Mark CondonFlowood$3K
- Sean DouglasHattiesburg$40K
- Robert HollabaughSouthaven$17K
- Kristopher WhiteheadTupelo$17K
- Harold BlalockJackson$15K
- Jon PoseyTupelo$13K
- Paul FarabaughTupelo$13K
- Clarance FarmerTupelo$12K
- Patrick DailyJackson$12K
- Kaitlen SchexnayderHattiesburg$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.